Freenome vs Recursion: Which AI Tool is Better in 2026?

Freenome is built for ai healthcare, wellness & medical users on a free tier plan, while Recursion targets ai healthcare, wellness & medical workflows on a free tier model — here's how they stack up feature by feature.

Share
Freenome compared with Recursion
ComparisonFreenomeRecursion
Pricing & free tierFreemiumFreemium
Starting priceFree, paid plans availableFree, paid plans available
Free trial / creditsExact allowance not recordedExact allowance not recorded
Credit card requiredNo credit card requiredNo credit card required
Foundation modelFine-tunedFine-tuned
BYOK / platform control
Locked
Locked
Category & tagsAI Healthcare, Wellness & MedicalAI Healthcare, Wellness & Medical
Core features & strengths
  • Multiomics technology: analyzes multiple types of biological data from blood to detect cancer signals
  • AI and machine learning platform: learns from large-scale clinical data to identify complex biological patterns associated with cancer
  • Personalized Cancer Detection approach: tailors screening based on the idea that every person and cancer is different
  • SimpleScreen test portfolio: a growing line of blood-based screening tests, starting with SimpleScreen CRC
  • AI-enabled drug discovery platform: combines automated lab experiments with machine learning models
  • Lab-in-the-loop system: a continuous cycle connecting physical automation and computational analysis
  • Design-Make-Test-Learn process: integrated workflow from biology insight to molecule design to testing
  • Disease-specific cellular engineering: used to generate high-dimensional biological data
Community rating4.5(0)4.5(0)
Get startedVisit Freenome Visit Recursion

The Verdict: Which Should You Choose?

👉 Choose Freenome if you need…

  • Specialists who want a dedicated ai healthcare, wellness & medical tool rather than a general assistant
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option
Try Freenome

👉 Choose Recursion if you need…

  • Anyone replacing a manual ai healthcare, wellness & medical process with something faster
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option
Try Recursion

Detailed tool breakdown

Freenome

Freenome is a private biotech company developing blood-based tests for early cancer detection. Its platform combines multiomics technology with artificial intelligence and machine learning to identify biological signals associated with cancer from a standard blood draw. The company's approach, called Personalized Cancer Detection, aims to make screening more individualized, accessible and effective. Its SimpleScreen portfolio of blood-based tests, starting with SimpleScreen CRC for colorectal cancer, represents the first offerings in a planned expanding lineup. Freenome is intended for healthcare providers, health systems and patients interested in early, less invasive cancer screening options, and is supported by ongoing clinical research programs.

Core use case & workflow

  • Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
  • Multiomics technology: analyzes multiple types of biological data from blood to detect cancer signals
  • AI and machine learning platform: learns from large-scale clinical data to identify complex biological patterns associated with cancer
  • Personalized Cancer Detection approach: tailors screening based on the idea that every person and cancer is different
  • SimpleScreen test portfolio: a growing line of blood-based screening tests, starting with SimpleScreen CRC
  • Standard blood draw testing: screening delivered through a routine blood draw rather than more invasive procedures
  • Clinical research program: drives discovery, development and validation of early cancer detection tests

Listed specifications & control

  • Primary category: AI Healthcare, Wellness & Medical.
  • Listed foundation model: Fine-tuned. Model availability can depend on the selected plan.
  • Managed platform: the listing reports no support for bringing your own API key.

Strengths in context

  • No separate strengths have been documented for this listing. Use the stated features above as a test checklist rather than treating an undocumented capability as a benefit.

Limitations & practical checks

  • No specific limitations are recorded for this tool. This is not evidence that it has none: test the output quality, export options and usage limits against your actual task.

Pricing realities

  • Directory pricing classification: Freemium. This label alone does not establish an exact allowance or subscription price.
  • Listed starting price: Free, paid plans available. Confirm billing cadence, taxes and included usage before paying.
  • The listing does not document an exact free allowance or trial duration.
  • The listing states that no credit card is required.

Recursion

Recursion is a biotechnology company that uses an AI-driven platform to discover and develop new medicines. It combines automated wet-lab experiments with machine learning models in what it calls a "lab-in-the-loop" system, mapping disease biology, designing drug candidates, and advancing them toward clinical trials. The company maintains its own pipeline of investigational drugs in areas like oncology and rare disease, and also partners with pharmaceutical companies to apply its technology to specific drug discovery challenges. This is not a consumer software product but a platform and company aimed at pharmaceutical partners, investors, and researchers interested in AI-driven biology and drug development, rather than individual end users seeking a subscription tool.

Core use case & workflow

  • Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today!
  • AI-enabled drug discovery platform: combines automated lab experiments with machine learning models
  • Lab-in-the-loop system: a continuous cycle connecting physical automation and computational analysis
  • Design-Make-Test-Learn process: integrated workflow from biology insight to molecule design to testing
  • Disease-specific cellular engineering: used to generate high-dimensional biological data
  • Molecule narrowing: uses its system to reduce millions of candidate molecules to a synthetically accessible shortlist
  • Clinical pipeline: wholly owned programs spanning oncology and rare disease indications
  • Pharma partnerships: collaborates with partners to target specific therapeutic challenges

Listed specifications & control

  • Primary category: AI Healthcare, Wellness & Medical.
  • Listed foundation model: Fine-tuned. Model availability can depend on the selected plan.
  • Managed platform: the listing reports no support for bringing your own API key.

Strengths in context

  • No separate strengths have been documented for this listing. Use the stated features above as a test checklist rather than treating an undocumented capability as a benefit.

Limitations & practical checks

  • No specific limitations are recorded for this tool. This is not evidence that it has none: test the output quality, export options and usage limits against your actual task.

Pricing realities

  • Directory pricing classification: Freemium. This label alone does not establish an exact allowance or subscription price.
  • Listed starting price: Free, paid plans available. Confirm billing cadence, taxes and included usage before paying.
  • The listing does not document an exact free allowance or trial duration.
  • The listing states that no credit card is required.

How to choose for your workflow

Compare finished work, not the first response

Give both tools the same brief and source material. Judge the final deliverable after corrections: factual accuracy, editable output, and how much work remains before you can use it.

Price the complete workflow

Count retries, exports, premium models and any separate hosting or API charges. A free allowance is useful for evaluation, but it does not establish the cost of a recurring production workload.

Check control and portability

Confirm which files, project data and settings you can export. Bringing your own API key is different from owning the application code or being able to run the product independently.

Validate rights and sensitive data

Check the terms for the exact plan and feature you intend to use. Commercial permission, private projects and protection against intellectual property claims are different commitments.